专利快速检索-快速检索全球专利，免费商用专利数据库-IPRDB

1. 发明专利

JP2014005225A Agent for suppressing appetite improvement and body weight gain 有权
标题翻译：用于抑制可见改善和体重增重的代理
公开(公告)号：JP2014005225A
公开(公告)日：2014-01-16
申请号：JP2012141283
申请日：2012-06-22
申请人： National Institute Of Advanced Industrial & Technology , 独立行政法人産業技術総合研究所 , Sapporo Breweries Ltd , サッポロビール株式会社 , Sapporo Holdings Ltd , サッポロホールディングス株式会社
发明人： OISHI KATSUTAKA , YAMAMOTO YUKIORI , ITO NANAKO , MIYAZAKI REKI , NAKAKITA YASUICHI , KANEDA HIROTAKA
IPC分类号： A61K35/74 , A23L1/30 , A61P1/14 , A61P3/04
摘要： PROBLEM TO BE SOLVED: To provide a novel use of a Lactobacillus brevis SBC8803 strain.SOLUTION: The agent for suppressing appetite improvement and body weight gain contains a bacterial cell or a processed bacterial cell of a SBC8803 (accession number: FERM BP-10632) strain belonging to Lactobacillus brevis.
摘要翻译：要解决的问题：提供短乳杆菌SBC8803菌株的新用途。解决方案：用于抑制食欲改善和体重增加的药物含有SBC8803的细菌细胞或加工细菌细胞（登录号：FERM BP-10632）属于短乳杆菌的菌株。

2. 发明专利

JP2015000851A 体温上昇剤审中-公开
标题翻译：身体温度升高剂
公开(公告)号：JP2015000851A
公开(公告)日：2015-01-05
申请号：JP2013124849
申请日：2013-06-13
申请人：独立行政法人産業技術総合研究所 , National Institute Of Advanced Industrial & Technology , サッポロビール株式会社 , Sapporo Breweries Ltd , サッポロホールディングス株式会社 , Sapporo Holdings Ltd
发明人： OISHI KATSUTAKA , YAMAMOTO YUKIORI , ITO NANAKO , MIYAZAKI REKI , NAKAKITA YASUICHI , KANEDA HIROTAKA
IPC分类号： A61K35/74 , A23L1/30 , A61P3/00
CPC分类号： A61K35/747 , A23K10/18 , A23K50/50 , A23L33/135
摘要：【課題】適度な体温上昇効果を有する新規の体温上昇剤を提供すること。【解決手段】ラクトバチラス・ブレビス(Lactobacillus brevis)に属するSBC8803(受託番号:FERM BP−10632)菌株の菌体又はその処理物を有効成分として含有する体温上昇剤。【選択図】なし
摘要翻译：要解决的问题：提供具有适当体温升高效果的新型体温升高剂。解决方案：本发明提供一种体温升高剂，其包含作为活性成分的菌株SBC8803（保藏号：FERM BP-10632）或其处理产物。

3. 发明专利

JP2013181005A Circadian rhythm improving medicine 有权
标题翻译： CIRCADIAN RHYTHM改进药物
公开(公告)号：JP2013181005A
公开(公告)日：2013-09-12
申请号：JP2012046806
申请日：2012-03-02
申请人： National Institute Of Advanced Industrial Science & Technology , 独立行政法人産業技術総合研究所 , Sapporo Breweries Ltd , サッポロビール株式会社 , Sapporo Holdings Ltd , サッポロホールディングス株式会社
发明人： OISHI KATSUTAKA , MIYAZAKI REKI , ITO NANAKO , YAMAMOTO YUKIORI , NAKAKITA YASUICHI , KANEDA HIROTAKA
IPC分类号： A61K35/74 , A23L1/30 , A23L2/52 , A61P25/00 , A61P25/20
CPC分类号： A61K35/74 , A23L2/382 , A23L2/52 , A23L33/135 , A23V2002/00 , A23Y2220/13 , A61K35/744
摘要： PROBLEM TO BE SOLVED: To provide a new circadian rhythm improving medicine.SOLUTION: Provided is a circadian rhythm improving medicine containing the bacterial cell of lactobacillus or processed product thereof as an active constituent.
摘要翻译：要解决的问题：提供新的昼夜节律改善药物。解决方案：提供一种含有乳酸杆菌的细菌细胞或其加工产物作为活性成分的昼夜节律改善药物。

4. 发明专利

JP2014139166A Improvement agent for abnormal glucose tolerance 有权
标题翻译：异丙醇耐量改良剂
公开(公告)号：JP2014139166A
公开(公告)日：2014-07-31
申请号：JP2013261692
申请日：2013-12-18
申请人： National Institute Of Advanced Industrial & Technology , 独立行政法人産業技術総合研究所 , Nisshin Seifun Group Inc , 株式会社日清製粉グループ本社 , Oriental Yeast Co Ltd , オリエンタル酵母工業株式会社
发明人： OISHI KATSUTAKA , ITO NANAKO , YAMAMOTO YUKIORI , FUKUTOME SHINICHI , KIKUCHI YOSUKE , OKITA KIMIKO
IPC分类号： A61K36/899 , A23K1/16 , A23L1/30 , A61K31/05 , A61P3/10
摘要： PROBLEM TO BE SOLVED: To provide an improvement agent for abnormal glucose tolerance capable of effectively preventing and treating abnormal glucose tolerance of humans or animals which develop diabetes or are incipient diabetics.SOLUTION: The improvement agent for abnormal glucose tolerance comprises a peak component of partition chromatography of an alcohol extract from a gramineous plant seed as an active ingredient. The peak component preferably comprises a mixture of a plurality of kinds of alkylresorcinol (AR). The mixture comprises AR in which Rin general formula (I) is a saturated or unsaturated alkyl group having 15C, AR in which Ris a saturated or unsaturated alkyl group having 17C, AR in which Ris a saturated or unsaturated alkyl group having 19C, AR in which Ris a saturated or unsaturated alkyl group having 21C, AR in which Ris a saturated or unsaturated alkyl group having 23C, and AR in which Ris a saturated or unsaturated alkyl group having 25C, by a specified amount.
摘要翻译：要解决的问题：提供能够有效预防和治疗发生糖尿病或初期糖尿病的人或动物异常葡萄糖耐量异常的葡萄糖耐量改善剂。解决方案：葡萄糖耐量异常的改善剂包括分配的峰分量从禾本科植物种子的醇提取物的色谱法作为活性成分。峰组分优选包含多种烷基间苯二酚（AR）的混合物。该混合物包含其中Rin通式（I）是具有15C的饱和或不饱和烷基的AR，其中R是具有17C的饱和或不饱和烷基的AR，其中R是具有19C的饱和或不饱和烷基，AR在其中R是具有21C的饱和或不饱和烷基，其中R是具有23℃的饱和或不饱和烷基的AR，其中R是具有25℃的饱和或不饱和烷基的AR，具有规定量。

5. 发明专利

JP2013200138A Biomarker for monitoring behavior rhythm 有权
标题翻译：生物标记用于监测行为RHYTHM
公开(公告)号：JP2013200138A
公开(公告)日：2013-10-03
申请号：JP2012067165
申请日：2012-03-23
申请人： National Institute Of Advanced Industrial & Technology , 独立行政法人産業技術総合研究所
发明人： MIYAZAKI REKI , OISHI KATSUTAKA , ITO NANAKO , YOSHIDA KOICHI , SHICHIRI MOTOTADA
IPC分类号： G01N33/92 , G01N33/15 , G01N33/50
摘要： PROBLEM TO BE SOLVED: To provide a biomarker capable of stably and highly accurately detecting oxidative stress circadian rhythm in a living body, and to provide a method for learning a body time of feeding rhythm that is not interlocked with manifestation of biological clock gene.SOLUTION: Hydroxyoctadecadienoic acids (HODE) in the blood, or 7-hydroxycholesterols (7-OHCh) as well as the HODEs are defines as biomarkers. A method includes: measuring them a plurality of times with age; and observing time-series changes in the measurement values. Thereby, circadian changes in the behavior rhythm such as feeding rhythm can be monitored, and an effective administration time of an oxidative stress-relieving material can be determined.
摘要翻译：要解决的问题：提供能够稳定且高精度地检测生物体中的氧化应激昼夜节律的生物标志物，并且提供一种用于学习与生物钟基因表达不互锁的喂养节奏的身体时间的方法。解决方案：血液中的羟基十八碳二烯酸（HODE）或7-羟基胆固醇（7-OHCh）以及HODE被定义为生物标志物。一种方法包括：随年龄测量多次; 并观察测量值的时间序列变化。因此，可以监测行为节律如进食节律的昼夜变化，并且可以确定氧化应激消除材料的有效施用时间。

6. 发明专利

JP2004323486A Prophylactic and therapeutic eye lotion for retina and/or uvea disease 审中-公开
公开(公告)号：JP2004323486A
公开(公告)日：2004-11-18
申请号：JP2003124605
申请日：2003-04-30
申请人： National Institute Of Advanced Industrial & Technology , 独立行政法人産業技術総合研究所
发明人： YOSHIDA KOICHI , ITO NANAKO , FUTAKI TOKIO , TANIDO MASAKI , OHIRA AKIHIRO
IPC分类号： A61K9/107 , A61K9/127 , A61K31/198 , A61K31/355 , A61K31/375 , A61K45/00 , A61P9/10 , A61P27/02 , A61P39/06
摘要： PROBLEM TO BE SOLVED: To provide a prophylactic and therapeutic eye lotion that effectively prevents and improves retina and/or uvea diseases, e.g., age-related macular degeneration or retinopathy of prematurity, or the like.
SOLUTION: This prophylactic and therapeutic eye lotion for retina and/or uvea diseases contains tocotrienols. Particularly, a tocotrienol as at least one selected from the group consisting of α-tocotrienol, β-tocotrienol, γ-tocotrienol and δ-tocotrienol is used to prepare the eye lotion for preventing and treating diseases of retina and uvea.
COPYRIGHT: (C)2005,JPO&NCIPI

7. 发明专利

JP2013256486A Circadian rhythm regulator 有权
标题翻译： CIRCADIAN RHYTHM调节器
公开(公告)号：JP2013256486A
公开(公告)日：2013-12-26
申请号：JP2012241533
申请日：2012-11-01
申请人： National Institute Of Advanced Industrial Science & Technology , 独立行政法人産業技術総合研究所 , Nisshin Seifun Group Inc , 株式会社日清製粉グループ本社 , Oriental Yeast Co Ltd , オリエンタル酵母工業株式会社
发明人： OISHI KATSUTAKA , MIYAZAKI REKI , ONISHI YOSHIAKI , TOMITA TATSUNOSUKE , ITO NANAKO , FUKUTOME SHINICHI , TANAKA KEIKO , KIKUCHI YOSUKE , KASUYA KENJI
IPC分类号： A61K31/05 , A61K36/18 , A61K36/899 , A61P25/02 , A61P25/20
CPC分类号： A61K31/05 , A61K36/185 , A61K2236/33 , C07C39/08
摘要： PROBLEM TO BE SOLVED: To provide a food-derived circadian rhythm regulator which is secure and safe even when it is taken for a long time.SOLUTION: A circadian rhythm regulator containing an alkylresorcinol represented by formula (I) as an effective component and a circadian rhythm regulator that contains, as an effective component, an alkylresorcinol-containing extract extracted from cereal or nuts containing the alkylresorcinol represented by formula (I) are provided. In formula (I), Ris a saturated or unsaturated alkyl group and R2 is a hydrogen atom or a methyl group. Further, in formula (I), Rand Rare preferably bonded in a para position and Ris preferably a 15-27C saturated or unsaturated alkyl group.
摘要翻译：要解决的问题：提供即使长时间服用也是安全和安全的食源性昼夜节律调节剂。解决方案：含有由式（I）表示的烷基间苯二酚作为有效成分的昼夜节律调节剂和提供了含有由含有由式（I）表示的烷基间苯二酚的谷物或坚果提取的含烷基间苯二酚的提取物作为有效成分的昼夜节律调节剂。在式（I）中，R是饱和或不饱和的烷基，R 2是氢原子或甲基。此外，在式（I）中，兰德Rare优选键合在对位，R 1优选为15-27℃饱和或不饱和烷基。

8. 发明专利

JP2013255481A Biomarker for predicting disturbance of circadian rhythm 有权
标题翻译：用于预测CIRCADIAN RHYTHM的干扰的生物标记
公开(公告)号：JP2013255481A
公开(公告)日：2013-12-26
申请号：JP2012144660
申请日：2012-06-27
申请人： National Institute Of Advanced Industrial Science & Technology , 独立行政法人産業技術総合研究所
发明人： OISHI KATSUTAKA , MIYAZAKI REKI , ITO NANAKO , YAMAMOTO YUKIORI
IPC分类号： C12Q1/68 , C12N15/09 , G01N33/15 , G01N33/50 , G01N33/53 , G01N33/68
摘要： PROBLEM TO BE SOLVED: To provide a method for predicting a circadian rhythm sleep disorder or circadian rhythm disturbance, particularly a marker for accurately and easily diagnosing the circadian rhythm sleep disorder.SOLUTION: A marker for diagnosing a circadian rhythm sleep disorder includes HSPA1a protein or an HSPA1a gene. Specifically, a method is provided for diagnosing the circadian rhythm sleep disorder or circadian rhythm disturbance by measuring the increase amount of the expression amount of the HSPA1a or its gene in a subject's blood, and a method is provided for screening a substance for improving the circadian rhythm sleep disorder or circadian rhythm disturbance by measuring the increase control amount of the expression amount of the HSPA1a or its gene in the blood of a circadian rhythm sleep disorder model mouse or a stress sleep disorder mouse dosed with a test substance.
摘要翻译：要解决的问题：提供一种用于预测昼夜节律睡眠障碍或昼夜节律紊乱的方法，特别是用于准确和容易地诊断昼夜节律睡眠障碍的标记。解决方案：用于诊断昼夜节律睡眠障碍的标记包括HSPA1a蛋白或 HSPA1a基因。具体而言，提供了通过测量受试者血液中HSPA1a或其基因的表达量的增加量来诊断昼夜节律睡眠障碍或昼夜节律紊乱的方法，并且提供了用于筛选用于改善昼夜节律的物质的方法通过测量伴随测试物质的昼夜节律睡眠障碍模型小鼠或应激性睡眠障碍小鼠血液中HSPA1a或其基因的表达量的增加控制量，来调节节律性睡眠障碍或昼夜节律紊乱。

你已经成功收藏专利！

检索式保存成功!

IPRDB

热门服务

关于我们

友情链接

联系方式